NIFTY 50 Close 28 Oct

HDFC Pharma And Healthcare Fund

Sectoral · Direct Growth Very High Risk

₹21.7150
NAV on 28-Oct-2026
Showing the Direct plan. The Regular plan you picked has the same portfolio but a higher expense ratio, so its NAV and returns are lower.
Fund size (AUM)
₹3,501 Cr
Expense ratio
1.05%
Since inception (CAGR)
+28.75%
Minimum SIP · lump sum
₹100 · ₹100

Returns

absolute up to 1Y, annualised beyond
1M3M6M1Y3Y5Y10Y
This fund-2.69%+0.80%+15.73%+22.81%+30.15%——
Category average—-4.89%+7.29%+6.47%+20.21%+14.60%—

About

Fund houseHDFC Mutual Fund
Fund managersNikhil Mathur
BenchmarkBSE Healthcare Total Return Index
Launched04-Oct-2023
ISININF179KC1HO1
Exit loadExit load of 1%, if redeemed within 30 days.

Risk

Standard deviation—
Sharpe ratio—
Sortino ratio—
Alpha—
Beta—

Top holdings

40 in total
HoldingSectorValue% of fund
Divi's Laboratories LtdHealthcare₹329 Cr9.39%
Sun Pharmaceutical Industries LtdHealthcare₹290 Cr8.28%
RepoUnspecified₹163 Cr4.67%
Alkem Laboratories LtdHealthcare₹163 Cr4.64%
Cipla LtdHealthcare₹145 Cr4.15%
Apollo Hospitals Enterprise LtdHealthcare₹129 Cr3.69%
Torrent Pharmaceuticals LtdHealthcare₹128 Cr3.65%
Max Healthcare Institute LtdHealthcare₹126 Cr3.61%
Aster DM Healthcare LtdHealthcare₹125 Cr3.56%
Lupin LtdHealthcare₹124 Cr3.55%
Neuland Laboratories LtdHealthcare₹114 Cr3.24%
Shilpa Medicare LtdHealthcare₹113 Cr3.23%
Dr. Reddy's Laboratories LtdHealthcare₹112 Cr3.19%
Ami Organics LtdHealthcare₹111 Cr3.18%
Anthem Biosciences Ltd.Healthcare₹111 Cr3.17%
Ipca Laboratories LtdHealthcare₹104 Cr2.98%
Global Health LtdHealthcare₹95 Cr2.72%
Rubicon Research Ltd.Healthcare₹88 Cr2.52%
Krishna Institute Of Medical Sciences LtdHealthcare₹73 Cr2.10%
Glenmark Pharmaceuticals LtdHealthcare₹73 Cr2.09%

Fetched 29 Oct, 17:41 IST. Past returns don't predict future returns. Source: Indian Stock API.